References

  1. Younes NA, Shafagoj Y, Khatib F, Ababneh M. Laboratory screening for hyperparathyroidism. Clin Chim Acta. 2005; 353(1-2):1-12. PubMed | Google Scholar

  2. Jouan A, Zabraniecki L, Vincent V, Poix E, Fournié B. Un mode de découverte inhabituel d'hyperparathyroïdie primitive : hypercalcémie majeure et tumeurs brunes multiples. Rev Rhum. 2008;75(3):289-91. PubMed | Google Scholar

  3. El Abdi B, Berrkia I, Mohssine A, El Hassani MR, El Quessar A, Chakir N, et al. Tumeur maxillaire révélant une hyperparathyroïdie primitive : à propos d'un cas. J Radiol. 2006;87 (3):1705-7. PubMed | Google Scholar

  4. Fraser WD. Hyperparathyroisme. Lancet. 2009;374(9684):145-58. PubMed | Google Scholar

  5. Catherine Cormier. Hyperparathyroïdie primitive. Revue du rhumatisme monographies. 2012;79(4):233-38. PubMed | Google Scholar

  6. Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med. 2005;257(1):6-17. PubMed | Google Scholar

  7. Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007; 92(8):3001-5. PubMed | Google Scholar

  8. Muriel B, Peter K. Hyperparathyroïdie primaire. Forum Med Suisse. 2009; 9(44):791. PubMed | Google Scholar

  9. Joseph Melton L. The epidemiology of primary hyperparathyroidism in North. America Journal of Bone and Mineral Research. 2002; 17(2):12-17. PubMed | Google Scholar

  10. Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96(8):2377-85. PubMed | Google Scholar

  11. Silverberg SJ, Bilezikian JP. Clinical presentation of primary hyperparathyroi-dism. In: Bilezikian JP, Marcus R, Levine MA, editors. The parathyroids: basic and clinical concepts. 2nd ed NewYork: Raven Press; 2001. p. 349-60. PubMed | Google Scholar

  12. Wémeau JL. Hyperparathyroïdie primaire. J Radiol. 2009; 90(3):392-6. PubMed | Google Scholar

  13. Catherine Cormier. Hyperparathyroïdie primitive Normocalcémique. Réflexions Rhumatologiques. N°135 - Tome 15 - janvier 2011. PubMed | Google Scholar

  14. Bilezikian JP, Potts JT JR, El-Hajj Fuleihan G, Kleerekoper M, Neer R, Peacock M et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism : a perspective for the 21st century. J Clin Endocrinol Metab. 2002; 87(12): 5353-5361. PubMed | Google Scholar

  15. Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab. 1996; 81(6): 2036-2040. PubMed | Google Scholar

  16. Silverberg SJ, Gao P, Brown I, LoGerfo P, Cantor TL, Bilezikian JP. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab. 2003; 88(10):4725-30. PubMed | Google Scholar

  17. Frank-Raue K, Leidig-Bruckner G, Haag C, Schulze E, Lorenz A, Schmitz-Winnenthal H, et al. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidim. Clin Endocrinol (Oxf). 2011;75(1):50-5. PubMed | Google Scholar

  18. Souberbielle JC, Maury E, Friedlander G, Cormier C. Vitamin D and primary hyperpa-rathyroidism (PHPT). J Steroid Biochem Mol Biol. 2010;121(1-2):199-203. PubMed | Google Scholar

  19. Suarez-Cunqueiro MM, Schoen R, Klisch J, Rainer S. Brown tumor of the mandible as first manifestation of atypical parathyroid adenoma. J Oral Maxillofac surg. 2004; 62(8):1024-1028. PubMed | Google Scholar

  20. Souberbielle JC. Examens biologiques. Réflexions Rhumatologiques. N°135 - Tome 15 - Janvier 2011.